Clinical Science Research and Development Service Cooperative Studies Scientific Evaluation Committee; Notice of Meeting, 31072 [2012-12522]

Download as PDF 31072 Federal Register / Vol. 77, No. 101 / Thursday, May 24, 2012 / Notices involve the immune system, magnetic resonance imaging, and alternative medical treatments (acupuncture, mindfulness, and Tai-Chi) for Gulf War Veterans. The session will also include discussion of Committee business and activities. The meeting will include time reserved in the afternoon on both days for public comments. Public comments will be limited to five minutes each. A sign-up sheet will be made available for those who wish to speak and will be accommodated on a first-come, firstserved basis. Individuals who speak are invited to submit a 1–2 page summary of their comments at the time of the meeting for inclusion in the official meeting record. Members of the public may also submit written statements for the Committee’s review to Dr. Victor Kalasinsky, Designated Federal Officer, Department of Veterans Affairs, 810 Vermont Avenue NW., Washington, DC, or by email at victor.kalasinsky@va.gov. Any member of the public seeking additional information should contact Dr. Kalasinsky at (202) 443–5682. Dated: May 18, 2012. By Direction of the Secretary. Vivian Drake, Committee Management Officer. [FR Doc. 2012–12574 Filed 5–23–12; 8:45 am] srobinson on DSK4SPTVN1PROD with NOTICES BILLING CODE P VerDate Mar<15>2010 16:31 May 23, 2012 Jkt 226001 DEPARTMENT OF VETERANS AFFAIRS Clinical Science Research and Development Service Cooperative Studies Scientific Evaluation Committee; Notice of Meeting The Department of Veterans Affairs (VA) gives notice under Public Law 92– 463 (Federal Advisory Committee Act) that a meeting of the Clinical Science Research and Development Service Cooperative Studies Scientific Evaluation Committee will be held on July 12, 2012, at the Sheraton Suites Old Town Alexandria, 801 North Saint Asaph Street, Alexandria, VA. The meeting will begin at 8:30 a.m. and end at 2 p.m. The Committee advises the Chief Research and Development Officer through the Director of the Clinical Science Research and Development Service on the relevance and feasibility of proposed projects and the scientific validity and propriety of technical details, including protection of human subjects. The session will be open to the public for approximately 30 minutes at the start of the meeting for the discussion of administrative matters and the general status of the program. The remaining portion of the meeting will be closed to PO 00000 Frm 00080 Fmt 4703 Sfmt 9990 the public for the Committee’s review, discussion and evaluation of research and development applications. During the closed portion of the meeting, discussions and recommendations will deal with qualifications of personnel conducting the studies, staff and consultant critiques of research proposals and similar documents and the medical records of patients who are study subjects, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. As provided by section 10(d) of Public Law 92–463, as amended, closing portions of this meeting is in accordance with 5 U.S.C. 552b(c)(6) and (c)(9)(B). Those who plan to attend should contact Dr. Grant Huang, Deputy Director, Cooperative Studies Program (10P9CS), Department of Veterans Affairs, 810 Vermont Avenue NW., Washington, DC 20420, at (202) 443– 5609 or by email at grant.huang@va.gov. Dated: May 18, 2012. By Direction of the Secretary. Vivian Drake, Committee Management Officer. [FR Doc. 2012–12522 Filed 5–23–12; 8:45 am] BILLING CODE 8320–01–P E:\FR\FM\24MYN1.SGM 24MYN1

Agencies

[Federal Register Volume 77, Number 101 (Thursday, May 24, 2012)]
[Notices]
[Page 31072]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-12522]


-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Clinical Science Research and Development Service Cooperative 
Studies Scientific Evaluation Committee; Notice of Meeting

    The Department of Veterans Affairs (VA) gives notice under Public 
Law 92-463 (Federal Advisory Committee Act) that a meeting of the 
Clinical Science Research and Development Service Cooperative Studies 
Scientific Evaluation Committee will be held on July 12, 2012, at the 
Sheraton Suites Old Town Alexandria, 801 North Saint Asaph Street, 
Alexandria, VA. The meeting will begin at 8:30 a.m. and end at 2 p.m.
    The Committee advises the Chief Research and Development Officer 
through the Director of the Clinical Science Research and Development 
Service on the relevance and feasibility of proposed projects and the 
scientific validity and propriety of technical details, including 
protection of human subjects.
    The session will be open to the public for approximately 30 minutes 
at the start of the meeting for the discussion of administrative 
matters and the general status of the program. The remaining portion of 
the meeting will be closed to the public for the Committee's review, 
discussion and evaluation of research and development applications.
    During the closed portion of the meeting, discussions and 
recommendations will deal with qualifications of personnel conducting 
the studies, staff and consultant critiques of research proposals and 
similar documents and the medical records of patients who are study 
subjects, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy. As provided by section 10(d) 
of Public Law 92-463, as amended, closing portions of this meeting is 
in accordance with 5 U.S.C. 552b(c)(6) and (c)(9)(B).
    Those who plan to attend should contact Dr. Grant Huang, Deputy 
Director, Cooperative Studies Program (10P9CS), Department of Veterans 
Affairs, 810 Vermont Avenue NW., Washington, DC 20420, at (202) 443-
5609 or by email at grant.huang@va.gov.

    Dated: May 18, 2012.

    By Direction of the Secretary.
Vivian Drake,
Committee Management Officer.
[FR Doc. 2012-12522 Filed 5-23-12; 8:45 am]
BILLING CODE 8320-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.